A
IONS icon

AlphaQuest’s Ionis Pharmaceuticals IONS Stock Holding History

AlphaQuest’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-670
Closed -$53K – 991
2025
Q4 		$53K Buy
670
+217
+48% +$16.3K ﹤0.01% 1928
2025
Q3 		$29.6K Sell
453
-382
-46% -$18.6K ﹤0.01% 2034
2025
Q2 		$33K Buy
835
+200
+31% +$6.54K ﹤0.01% 1717
2025
Q1 		$19.2K Buy
+635
New +$20.8K ﹤0.01% 1707
2024
Q4 		– Sell
-2,674
Closed -$107K – 1852
2024
Q3 		$107K Buy
2,674
+1,301
+95% +$60.5K 0.01% 1266
2024
Q2 		$65.4K Sell
1,373
-924
-40% -$37.9K 0.01% 1028
2024
Q1 		$99.6K Buy
2,297
+2,296
+229,600% +$109K 0.02% 820
2023
Q4 		$51 Buy
+1
New +$48 ﹤0.01% 1052

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlphaQuest's IONS Position: Q1 2026 in Review

AlphaQuest sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 670 shares — an estimated $53K sold.

AlphaQuest first reported a position in IONS in Q4 2023 and held it in 8 quarters. The position peaked at $107K in Q3 2024. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • AlphaQuest reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 670 Ionis Pharmaceuticals shares in Q1 2026, an estimated $53K.
  • AlphaQuest first reported a position in Ionis Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Ionis Pharmaceuticals position peaked at $107K in Q3 2024.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.